Company Legal Name
Latest Valuation
Founded Year
Headquarter
Truemeds operates as an e-pharmacy platform based in Mumbai, India, specializing in providing affordable generic medicine alternatives to consumers. The company differentiates itself by offering significant cost savings on prescription medications while maintaining quality standards through verified suppliers. Truemeds has integrated teleconsultation services with licensed healthcare professionals alongside its core pharmacy operations, creating a comprehensive digital healthcare ecosystem. The platform provides convenient home delivery services, addressing the growing demand for accessible healthcare solutions in India's expanding digital health market. Currently, Truemeds focuses on scaling its operations and expanding its generic medicine portfolio to serve India's price-sensitive healthcare consumers.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





